The other lesson from the lecanemab debate is that prescribing a drug is no longer just about the drug any more. We need an infrastructure of genetic testing, rapid imaging, infusion clinics, and more ...

More than 30 years after early warnings about antidepressant-linked suicidality and violence were downplayed, new peer-reviewed studies are again raising concerns ...